JP2011519910A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519910A5
JP2011519910A5 JP2011508009A JP2011508009A JP2011519910A5 JP 2011519910 A5 JP2011519910 A5 JP 2011519910A5 JP 2011508009 A JP2011508009 A JP 2011508009A JP 2011508009 A JP2011508009 A JP 2011508009A JP 2011519910 A5 JP2011519910 A5 JP 2011519910A5
Authority
JP
Japan
Prior art keywords
ono
independently
alkyl
cycloalkoxy
alkoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519910A (ja
JP5401540B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/005594 external-priority patent/WO2009136281A1/en
Publication of JP2011519910A publication Critical patent/JP2011519910A/ja
Publication of JP2011519910A5 publication Critical patent/JP2011519910A5/ja
Application granted granted Critical
Publication of JP5401540B2 publication Critical patent/JP5401540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508009A 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類 Active JP5401540B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US61/052,084 2008-05-09
US13933308P 2008-12-19 2008-12-19
US61/139,333 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (3)

Publication Number Publication Date
JP2011519910A JP2011519910A (ja) 2011-07-14
JP2011519910A5 true JP2011519910A5 (enExample) 2012-03-15
JP5401540B2 JP5401540B2 (ja) 2014-01-29

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508009A Active JP5401540B2 (ja) 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類

Country Status (8)

Country Link
US (1) US8101658B2 (enExample)
EP (1) EP2274279B1 (enExample)
JP (1) JP5401540B2 (enExample)
CN (1) CN102099330B (enExample)
AR (1) AR076731A1 (enExample)
CA (1) CA2723704C (enExample)
ES (1) ES2428387T3 (enExample)
WO (1) WO2009136281A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005505A2 (en) * 2009-06-22 2011-01-13 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
US8865766B2 (en) * 2011-02-14 2014-10-21 Allergan, Inc. Ester derivatives of bimatoprost compositions and methods
WO2013132498A2 (en) 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2013181332A1 (en) 2012-05-31 2013-12-05 Theravance, Inc. Nitric oxide donor neprilysin inhibitors
WO2016155906A1 (en) 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
EP4548975A3 (en) 2015-09-09 2025-07-23 Beyond Air Ltd Nitric oxide inhalation therapy for infants with bronchiolitis
WO2018087092A1 (en) 2016-11-08 2018-05-17 Bausch & Lomb Incorporated Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
ES2923623T3 (es) 2018-02-21 2022-09-29 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
RU2718744C2 (ru) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
TWI839364B (zh) 2018-07-12 2024-04-21 法國商尼可斯股份有限公司 包含釋放一氧化氮的前列醯胺之眼用組成物
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
PL4288413T3 (pl) 2021-02-03 2025-04-28 Nicox S.A. Sposób wytwarzania analogu prostaglandyny będącego donorem tlenku azotu
US20240390390A1 (en) 2021-09-20 2024-11-28 Nicox Sa Nitric oxide releasing prostamide as neuroprotective agent
CN119350280A (zh) * 2021-11-18 2025-01-24 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
RS66198B1 (sr) 2022-07-07 2024-12-31 Nicox Sa Industrijski postupak za pripremu heksanske kiseline, 6(nitrooksi)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(etilamino)-7-okso-2-hepten-1-il]3,5- dihidroksiciklopentil]-1-(2-fenil etil)-2-propen-1-il estra i visoko čistog proizvoda
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药(常熟)有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
HK1080448A1 (zh) * 2002-03-01 2006-04-28 Allergan, Inc. 前列腺酰胺的制备
OA13356A (en) * 2004-01-05 2007-04-13 Nicox Sa Prostaglandin nitrooxyderivatives.
WO2007000641A2 (en) 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Similar Documents

Publication Publication Date Title
JP2011519910A5 (enExample)
JP2008514611A5 (enExample)
JP2008525416A5 (enExample)
JP2010515731A5 (enExample)
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
JP2008255122A5 (enExample)
JP2007511546A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2013510857A5 (enExample)
JP2011516610A5 (enExample)
JP2009504764A5 (enExample)
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
JP2010529147A5 (enExample)
JP2007510662A5 (enExample)
JP2010510967A5 (enExample)
JP2008504265A5 (enExample)
JP2007302689A5 (enExample)
JP2013515037A5 (enExample)
JP2005536503A5 (enExample)
JP2008546770A5 (enExample)
JP2011529502A5 (enExample)
JP2010508310A5 (enExample)
JP2007502817A5 (enExample)
JP2010534246A5 (enExample)